Rayan Saleh Moussa
Dr Rayan Saleh Moussa is the Cancer Symptom Trials (CST) Postdoctoral Research Fellow. She was awarded her doctorate in the area of cancer therapeutics in 2017 by The University of Sydney.
Her postdoctoral research is focused on improving the preclinical to clinical pipeline through multidisciplinary translational research in cancer symptom therapeutics and interventions.
Rayan has a Bachelor of Medical Science (Hons) from the University of Sydney. Her PhD focused on how iron chelators, a class of anti-cancer drugs, can slow or stop cancer growth through limited uptake of iron.
She made the transition from the lab to clinical research when she commenced her role at CST in 2019, where she is leading projects focused on delirium prevention and malignant wounds that aim to improve the quality of life and wellbeing of people living with cancer. She is also leading a project to investigate the underrepresentation of culturally and linguistically diverse (CALD) communities in clinical research with a view to seeking ways to improve health outcomes in these communities.
Current Projects:
• Diversity and inclusion in cancer clinical trials - CALD project (www.uts.edu.au/cst/cald)
• Bright light therapy for the prevention of delirium in hospitalised adults with advanced cancer – BLiPD project
• Honey on Wounds project (www.uts.edu.au/honey-wounds)
Abstracts this author is presenting: